0001382963-18-000137.txt : 20181026 0001382963-18-000137.hdr.sgml : 20181026 20181025215927 ACCESSION NUMBER: 0001382963-18-000137 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181026 DATE AS OF CHANGE: 20181025 EFFECTIVENESS DATE: 20181026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kato Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001756482 IRS NUMBER: 452899951 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-324435 FILM NUMBER: 181140191 BUSINESS ADDRESS: STREET 1: 26051 MERIT CIRCLE STREET 2: SUITE 102 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 BUSINESS PHONE: (949) 348-1188 MAIL ADDRESS: STREET 1: 26051 MERIT CIRCLE STREET 2: SUITE 102 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 D 1 primary_doc.xml X0708 D LIVE 0001756482 Kato Pharmaceuticals, Inc. 26051 MERIT CIRCLE SUITE 102 LAGUNA HILLS CA CALIFORNIA 92653 (949) 348-1188 DELAWARE None None Corporation true Terrance S. McGovern 26051 Merit Circle, Suite 102 Laguna Hills CA CALIFORNIA 92653 Executive Officer Director Hugh Neuharth 26051 Merit Circle, Suite 102 Laguna Hills CA CALIFORNIA 92653 Executive Officer Olav B. Berghein 26051 Merit Circle, Suite 102 Laguna Hills CA CALIFORNIA 92653 Director Mauro Bove 26051 Merit Circle, Suite 102 Laguna Hills CA CALIFORNIA 92653 Director Pharmaceuticals Decline to Disclose 06b false 2018-10-11 false true true true false 0 8000026 8000026 0 false 9 0 0 0 false Kato Pharmaceuticals, Inc. /s/ Hugh Neuharth Hugh Neuharth Chief Financial Officer 2018-10-25